Quorum Innovations has secured extensive intellectual property protection around Qi601 and its underlying biofilm architecture. We have over 50 issued patents across the United States, the European Union, China, Japan, Korea, Israel, Thailand, and Australia, with approximately 20 additional patents pending worldwide. The USPTO, the European Patent Office and patent authorities across multiple continents have recognized the uniqueness of Quorum’s discoveries, issuing patents that protect the bacterium itself, its biofilm-derived cellular mass, its manufacturing methods, and its application as a barrier and plastic decontamination technology. This broad and growing portfolio affirms the novelty, scientific merit, and global relevance of Quorum’s inventions — establishing the company as a leader in biofilm-based protective platforms and anchoring Qi601 as a first-in-class solution for defending human health against environmental plastics.
U.S. Patent 9,504,739. Method of Identifying Biologically Active Compounds from Microbial Biofilm. (Issued 11/2016; Priority 3/2011)
U.S. Patent 9,706,778. Materials and Methods for Improving Immune Responses and Skin and/or Mucosal Barrier Functions. (Issued 7/2017)
U.S. Patent 9,713,631. Method of Identifying Biologically Active Compounds from Microbial Biofilm; Manipulating a Microbiome with a Biologically Active Composition. (Issued 7/2017)
U.S. Patent 9,717,756. Method of Identifying Biologically Active Compounds from Microbial Biofilm; Method of Preparing a Biologically Active Composition. (Issued 8/2017)